Meet the antiaging zombie compound longevity researchers take
Looking to meet the antiaging zombie cell compound buzzing through longevity circles? It is fisetin, a plant polyphenol now sold in capsules for as little as $44. Harvard researcher David Sinclair reportedly takes about 500 mg a day. Mouse studies link chronic use to longer healthspan and lifespan, but human evidence is still limited.
Key Takeaways
- Fisetin is a natural flavonoid sold as a budget-friendly anti-aging supplement amid the wider longevity and biohacking boom.
- It acts as a senolytic, designed to clear senescent “zombie” cells that stall division yet keep inflaming nearby tissue.
- David Sinclair reportedly takes roughly 500 mg of fisetin daily, even as human trials remain thin.
- Chronic fisetin use has extended median and maximum lifespan in mice and improved healthspan in those studies.
- As with any supplement, consult a physician before adding fisetin to a longevity stack.
What are “zombie cells,” and how does fisetin target them?
Senescent cells earn the nickname “zombie cells” because they stop dividing but refuse to die. Over time they can pile up and release inflammatory molecules that damage surrounding tissue and push neighboring cells into the same stalled state.
Fisetin is described as a potent senolytic: a compound that selectively eliminates those dysfunctional cells. That cellular clean-up pitch is why shoppers and some scientists now treat the flavonoid as an accessible longevity tool rather than a lab-only curiosity.
Why are longevity researchers taking fisetin themselves?
Human studies are limited, yet that has not stopped scientists from adding fisetin to their personal stacks. According to the New York Post, world-famous Harvard researcher David Sinclair reportedly takes about 500 mg of fisetin per day.
The draw is practical as well as scientific. Capsule products are widely listed online right now, with prices starting around $44, placing the compound far below Hollywood’s pricey NAD+ trend or the multimillion-dollar anti-aging protocols popularized by tech mogul Bryan Johnson.
Does the anti-aging evidence hold up beyond mice?
In mouse research, chronic fisetin supplementation improved healthspan — the years spent in good health — and extended both median and maximum lifespan. While the research is still emerging, researchers like Sinclair believe the findings are quite promising for healthy aging.
Those animal results do not yet prove the same payoff in people. For a deeper look at the preclinical fisetin data, see this peer-reviewed EBioMedicine study on fisetin as a senotherapeutic. Talk with a physician before use.